SECISBP2 antibody (Middle Region)
Quick Overview for SECISBP2 antibody (Middle Region) (ABIN954708)
Target
See all SECISBP2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 500-530, Middle Region
-
Specificity
- Recognizes SECISBP2 (Center).
-
Purification
- Protein A column followed by peptide Affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 500-530 amino acids from the Central region of Human SECISBP2 Genename: SECISBP2
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SECISBP2 (SECIS Binding Protein 2 (SECISBP2))
-
Alternative Name
- SECISBP2
-
Background
- The incorporation of selenocysteine into a protein requires the concerted action of an mRNA element called a sec insertion sequence (SECIS), a selenocysteine-specific translation elongation factor and a SECIS binding protein. With these elements in place, a UGA codon can be decoded as selenocysteine. The gene described in this record encodes a nuclear protein that functions as a SECIS binding protein. Mutations in this gene have been associated with a reduction in activity of a specific thyroxine deiodinase, a selenocysteine-containing enzyme, and abnormal thyroid hormone metabolism.Synonyms: SBP2, SECIS-binding protein 2, Selenocysteine insertion sequence-binding protein 2
-
Gene ID
- 79048
-
NCBI Accession
- NP_076982
Target
-